To understand the regulation of cell proliferation by tyrosine phosphorylation, characterization of protein tyrosine phosphatases (PTPase; protein-tyrosine-phosphate phosphohydrolase, EC 3.1.3.48) is essential. The human genes LCA (leukocyte common antigen) and LAR encode putative receptor-linked PTPases. By using consensus sequence probes, two additional receptor-linked PTPase genes, DLAR and DPTP, were isolated from Drosophila melanogaster. The extracellular segments of both DLAR and DPTP are composed of multiple immunoglobulin-like domains and fibronectin type III-like domains. The cytoplasmic region of DLAR and DPTP, as well as human LCA and LAR, are composed of two tandemly repeated PTPase domains. PTPase activities of immunoprecipitated LCA and LAR were demonstrated by measuring the release of phosphate from a 32P-labeled [Tyr(P)]peptide. Fur-
2.7.1.112) is critically important in the regulation of cell growth and proliferation (1, 2) . Although protein tyrosine phosphatases (PTPases; protein-tyrosine-phosphate phosphohydrolase, EC 3.1.3.48) could be equally important in this regulation, their properties are not well characterized. Recently, the human placental PTPase 1B, a 35-kDa soluble enzyme, was purified and its amino acid sequence was partially determined (3, 4) . Amino acid sequence comparison suggests that the cytoplasmic regions of two human transmembrane molecules, the leukocyte common antigen (LCA, also called CD45, Ly-5, T200, or B220) and LAR, which was isolated by cross-hybridization to a LCA cDNA probe, contain two tandemly repeated PTPase lB-like domains (4) (5) (6) . The expression of LCA is restricted to hematopoietic cells, whereas the expression of LAR seems to be mainly on cells of epithelial origin. PTPase activity of purified LCA has been demonstrated (7) . The structures of LCA and LAR suggest that they are receptor-linked PTPases and raise the possibility that their phosphatase activities are controlled by their interaction with specific ligands. Thus, regulation of protein phosphorylation by PTPases may be as important as the regulation by PTKases. In this report, we describe two newly discovered Drosophila genes, DLAR and DPTP, that encode putative receptor-linked PTPases, and we demonstrate tyrosine-specific phosphatase activities of human LCA and LAR and Drosophila DLAR and DPTP.
MATERIALS AND METHODS
Buffers. Lysis buffer: 20 mM Tris-HCl, pH 8.0/150 mM NaCl/1 mM EDTA/1% (vol/vol) Triton X-100/1 mM phenylmethylsulfonyl fluoride/2 x Denhardt's solution (1 x Denhardt's solution = 0.02% bovine serum albumin/0.02% Ficoll/0.02% polyvinylpyrrolidone). Lysozyme buffer: 33 mM Tris'HCl, pH 8.0/2.5 mM EDTA/10 mM 2-mercaptoethanol. 10x phosphatase buffer: 250 mM Hepes, pH 7.3/50 mM EDTA/100 mM dithiothreitol.
Isolation of cDNA Clones. A cDNA library made from 4-to 8-hr Drosophila embryos (8) was screened with the following degenerate oligonucleotides: PTP-I, GTICA(C/T)TG(C/
T)TC(A/C/G/T)GC(A/C/G/T)GGIGT; PTP-II, GTICA(C/ T)TG(C/T)AG(C/T)GC(A/C/G/T)GGIGT. A 5' region
probe was prepared from DLAR23, and another Drosophila cDNA library made from 3-to 8-hr embryos (9) was screened to isolate DLAR55. The nucleotide sequences were determined by the dideoxynucleotide chain-termination method (10) using modified T7 DNA polymerase (11) .I'
Substrates for Phosphatase Assays. The synthetic peptide Raytide (Oncogene Science, Manhasset, NY) or angiotensin II (Sigma) was labeled at its tyrosine residue using [y-32P]ATP and v-abl tyrosine kinase (Oncogene Science). Partially dephosphorylated casein hydrolyzate (Sigma) was labeled at serine residues with [y-32P]ATP and the catalytic subunit of bovine heart cAMP-dependent protein kinase (Sigma).
Phosphatase Assay. The phosphatase assay mixture (50 ,ul) 'IThe sequences reported in this paper have been deposited in the GenBank data base (accession nos. M27699 and M27700).
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The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. (12) . One milliliter of cell extract was mixed with the appropriate preformed immune complex and incubated at 40C for 12 hr, sedimented by a 10-sec centrifugation in a microcentrifuge, washed four times with lysis buffer and then four additional times with PBS, and suspended in 50 /.l of PBS.
Bacterial Extracts.-Isopropyl 3-D-thiogalactoside (final concentration, 1 mM) was added to exponentially growing cultures of Escherichia coli DHB4 [AphoA Pvu II phoR (F' lacIQ pro)] (13) carrying plasmids, and cultures were shaken at 30'C for 2 hr. Cells in 1.5-ml cultures were precipitated in a microcentrifuge and resuspended in 200 gl of lysozyme buffer containinghen egg lysozyme (1.0 mg/ml). After 10 min at room temperature, cells were lysed by three cycles of freezing-thawing. Ten microliters of 0.2 M MgCl2 and 5 gl of DNase I (5 mg/ml) were added to the lysates and incubated at 250C for 20 min, followed by addition of 20 tkl of 0.2 M EDTA and 26 pkl of 10% Triton X-100, and incubated at 250C for 10 min. Protein contents of the extracts were determined according to Bradford (14) .
Plasmid Constructions and in Vitro Mutagenesis. For plasmid constructions, see Fig. 6 . In vitro site-directed mutagenesis was done essentially according to Foss and McClain (15) .
Other Methods. All other molecular biological procedures are according to standard methods (16 Fig. 2 .
Structures of DLAR and DPTP Molecules. The N terminus of DLAR has a hydrophobic stretch characteristic of a signal peptide. The most likely cleavage site is between the 32nd and 33rd amino acids from the N terminus (17) . The mature DLAR protein is a transmembrane protein with a 1345-aa extracellular region, a 25-aa transmembrane segment, and a 627-aa cytoplasmic region. The cytoplasmic region of DLAR, which is homologous to LAR (72% identity; Fig. 2A ), is composed of two repeated PTPase domains (DLAR-Cyl and -Cy2; Fig. 3 ). Although the similarity between the extracellular regions of DLAR and LAR is only 36%, the overall structures are very similar. As has been observed for LAR (6) , the N-terminal region of DLAR is composed of three tandemly repeated immunoglobulin-like domains that have significant similarity to neural cell adhesion molecule (N-CAM) (18) (data not shown). These immunoglobulin-like domains are followed by nine repeated domains that share structural features of the fibronectin (FN) type III repeat unit (19) (data not shown). In contrast, the human LAR has only eight FN type III-like repeat units.
DPTP also encodes a transmembrane protein with a 23-aa signal peptide, a 782-aa extracellular region, an 18-aa transmembrane segment, and a 639-aa cytoplasmic region (Fig.  2B) . The cytoplasmic region of DPTP is composed of two repeated PTPase domains (DPTP-Cyl and -Cy2; Fig. 3 ). The N-terminal region of DPTP contains two tandemly repeated immunoglobulin-like domains, which are followed by two FN type III-like domains (data not shown).
The structures of DLAR, DPTP, and several related molecules are schematically shown in Fig. 4 . The organizations of the extracellular regions of LAR, DLAR, and DPTP, which consist of several immunoglobulin-like domains and FN type III-like domains, are typical of a CAM family that includes N-CAM, fasciclin II, and Li (18, 21, 22) . Thus, it is possible that LAR, DLAR, and DPTP are cell adhesion receptors.
PTPase Activities of LCA and LAR. LCA is composed of several isoforms ranging in size between 220 and 180 kDa that are generated by tissue-specific splicing (5, 20, 23) . The largest 220-kDa isoform of LCA was partially purified by immunoprecipitation from the human B-cell line Raji using monoclonal anti-LCA antibodies 2H4 or GAP8.3 (24, 25) . To measure PTPase activities, immunoprecipitates were incubated with [Tyr(2P)]Raytide, a modified gastrin peptide, and the amount of radioactivity released as inorganic phosphate was determined. As shown in Fig. 5A , immunoprecipitates using 2H4 or GAP8.3 had PTPase activity, whereas control immunoprecipitates (2G9 or W6/32) had no detectable phosphatase activity. The tyrosine specificity of the LCA phosphatase was assessed by assaying the same immunoprecipitates for protein serine phosphatase activity, using [Ser 2P)]casein hydrolyzate as substrate. As Fig. 5B shows, none of the immunoprecipitates had detectable serine phosphatase activity. To test whether the smallest LCA isoform (180 kDa) has PITPase activity, a mouse B-cell line, 300-19, was transfected with a cDNA construct (pMT-LCA.1; Fig.  6A ) that encodes the 180-kDa human LCA isoform, and cell-surface-expressed LCA was immunoprecipitated with the monoclonal anti-LCA antibody UCHL-1. Fig. SC shows that the 180-kDa LCA isoform also has PTPase activity. To make it possible to purify the human LAR molecule by immunoprecipitation, we modified the LAR cDNA sequence so that it includes the epitope for the monoclonal antibody UCHL-1 (pMT-UC-LAR; Fig. 6A ). The UCHL-1 epitope has been mapped to the N terminus of the 180-kDa LCA isoform (25) . The modified LAR molecule expressed on transfected 300-19 cells and immunoprecipitated by the UCHL-1 antibody had PTPase activity (Fig. SD) .
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Expression of Phosphatase Domains in E. coli. To study the PTPase domains in more detail, we inserted the cytoplasmic segments of the LCA, LAR, DLAR, and DPTP cDNA sequences into the prokaryotic expression vector pKKUC12 (Fig. 6B) . The E. coli strain DHB4 (13) was transformed with these plasmids, and after induction by isopropyl ,B-D-thiogalactoside, extracts were prepared and assayed for PTPase activity. As Table 1 shows, cytoplasmic domains of LCA, LAR, DLAR, and DPTP expressed in E. coli have PTPase activities.
Mutations in Conserved Cysteine Residues. Because the placenta PTPase 1B is inhibited by various reagents that block cysteinyl groups, at least one cysteine is essential for PTPase activity (3) . The comparison of the PTPase sequences in Fig. 3 (Table 1) can be summarized as follows. The mutations at amino acid positions 737, 1047, and 1144 have no effect on the PTPase activity. On the other hand, the mutation at amino acid position 828 completely abolishes the PTPase activity. While it is possible that the 828S mutation affects both PTPase domains by changing protein conformation, a more plausible interpretation is that in our in vitro assay only the first PTPase domain has detectable activity, and for this activity Cys-828 is essential. One possible reason why the second PTPase domain of LCA has no activity in our in vitro However, there was no qualitative difference between Raytide and angiotensin II (Table 1) . This result weakens, but does not exclude, the possibility that substrate specificity is the reason why the second PTPase domain is inactive. The trivial explanation that the second PITPase domain of LCA is intrinsically inactive seems unlikely, because the amino acid sequences of this domain are strongly conserved between mouse, rat, and human. Finally, it is possible that the activity of the second PTPase domain is specifically regulated (for example, by ligand binding). Assays were done at 37°C for 30 min. Results in most cases are the average of two independent experiments. Speculation. From the structure and enzymatic activity, there emerges a possible scenario for the function of these receptor-linked PTPases. When a proliferating cell that expresses, for example, DLAR, encounters another cell that expresses the cell-surface ligand for DLAR, the molecular interaction between these molecules may activate the cytoplasmic PTPase, causing cessation of cell growth by counteracting the effects of PTKases. This might be a mechanism that underlies the contact inhibition of cell growth and motility. It is even possible that the ligand of DLAR is another receptor-linked PTPase, such as DPTP, so that their effects are reciprocal. Because failure of this mechanism could result in unrestricted cell proliferation, these receptorlinked PTPases are candidates for anti-oncogenes (28) .
